Related Experiment Video
Updated: Jun 18, 2025

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Endophytic fungi: A future prospect for breast cancer therapeutics and drug development
Sherin Varghese1, M S Jisha1, K C Rajeshkumar2
1School of Biosciences, Mahatma Gandhi University, Kottayam, Kerala, 686560, India.
Abstract:
Globally, breast cancer is a primary contributor to cancer-related fatalities and illnesses among women. Consequently, there is a pressing need for safe and effective treatments for breast cancer. Bioactive compounds from endophytic fungi that live in symbiosis with medicinal plants have garnered significant interest in pharmaceutical research due to their extensive chemical composition and prospective medicinal attributes. This review underscores the potentiality of fungal endophytes as a promising resource for the development of innovative anticancer agents specifically tailored for breast cancer therapy. The diversity of endophytic fungi residing in medicinal plants, success stories of key endophytic bioactive metabolites tested against breast cancer and the current progress with regards to in vivo studies and clinical trials on endophytic fungal metabolites in breast cancer research forms the underlying theme of this article. A thorough compilation of putative anticancer compounds sourced from endophytic fungi that have demonstrated therapeutic potential against breast cancer, spanning the period from 1990 to 2022, has been presented. This review article also outlines the latest trends in endophyte-based drug discovery, including the use of artificial intelligence, machine learning, multi-omics approaches, and high-throughput strategies. The challenges and future prospects associated with fungal endophytes as substitutive sources for developing anticancer drugs targeting breast cancer are also being highlighted.
Insights
Endophytic fungi from medicinal plants offer a promising source for novel breast cancer treatments. This review highlights their bioactive compounds and potential for developing new anticancer drugs.
Area of Science:
- Pharmacology
- Mycology
- Oncology
Background:
- Breast cancer remains a leading cause of cancer-related deaths in women globally, necessitating novel therapeutic strategies.
- Endophytic fungi, symbiotic microorganisms residing within medicinal plants, produce diverse bioactive compounds with significant pharmaceutical potential.
- These fungal endophytes are increasingly recognized as a valuable resource for discovering new anticancer agents.
Purpose of the Study:
- To review the potential of endophytic fungi as a source for developing innovative anticancer agents for breast cancer therapy.
- To compile and analyze bioactive metabolites from endophytic fungi with demonstrated therapeutic potential against breast cancer from 1990 to 2022.
- To discuss current trends, challenges, and future prospects in endophyte-based drug discovery for breast cancer.
Main Methods:
- Comprehensive literature review of scientific databases (e.g., PubMed, Scopus) from 1990 to 2022.
- Identification and compilation of endophytic fungi and their bioactive metabolites with reported anticancer activity against breast cancer.
- Analysis of current research trends, including artificial intelligence, machine learning, and multi-omics approaches in endophyte-based drug discovery.
Main Results:
- A wide array of endophytic fungi from medicinal plants harbor bioactive compounds with potent anticancer activities against breast cancer cell lines.
- Several key endophytic metabolites have shown promising results in preclinical (in vivo) studies and are progressing towards clinical trials.
- The review details specific compounds, their sources, mechanisms of action, and efficacy against various breast cancer models.
Conclusions:
- Endophytic fungi represent a rich and underexplored reservoir for the discovery of novel, effective, and potentially safer anticancer drugs for breast cancer treatment.
- Integration of advanced technologies like AI and multi-omics can accelerate the identification and development of these fungal-derived therapeutics.
- Further research and clinical investigations are crucial to fully harness the therapeutic potential of endophytic fungi in combating breast cancer.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Mitogens and the Cell Cycle